Exploring the therapeutic role of Moringa oleifera in neurodegeneration: antioxidant, anti-inflammatory, and neuroprotective mechanisms
Neurodegenerative disorders like Alzheimer's disease, Parkinson's disease, and other cognitive impairment conditions in elderly are defined by progressive loss of neurons, based mostly on oxidative stress, long-term neuroinflammation, and compromised neuroplasticity. In the midst of increa...
Saved in:
Published in | Inflammopharmacology Vol. 33; no. 7; pp. 3653 - 3669 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
Switzerland
01.07.2025
|
Subjects | |
Online Access | Get full text |
ISSN | 0925-4692 1568-5608 1568-5608 |
DOI | 10.1007/s10787-025-01794-y |
Cover
Loading…
Abstract | Neurodegenerative disorders like Alzheimer's disease, Parkinson's disease, and other cognitive impairment conditions in elderly are defined by progressive loss of neurons, based mostly on oxidative stress, long-term neuroinflammation, and compromised neuroplasticity. In the midst of increasing investigation for natural drugs, Moringa oleifera, a plant highly accepted for its high nutritional and phytochemical constitution, has become an active candidate with multi-oriented neuroprotective activity. This review discusses the therapeutic potential of Moringa oleifera in neurodegeneration, based on its antioxidant, anti-inflammatory, and neuroprotective activities. The plant's bioactive molecules, flavonoids, phenolic acids, and vitamins exhibit potent free radical-scavenging activity and the ability to modulate crucial inflammatory signaling pathways, like NF-κB and MAPK signaling. Additionally, Moringa oleifera is shown to possess the potential for enhancing neurogenesis, facilitating synaptic plasticity, and neuronal apoptosis protection. Preclinical evidence supports its efficacy in decreasing neuropathological alterations and enhancing cognitive function, whereas initial clinical data suggest a benign safety profile. In spite of these promising observations, additional work is required to confirm its action in human subjects and to standardize therapeutic regimens. This review highlights the promise of Moringa oleifera as an adjunct treatment for the prevention and management of neurodegenerative disorders and points to avenues for future investigation and clinical utility. |
---|---|
AbstractList | Neurodegenerative disorders like Alzheimer's disease, Parkinson's disease, and other cognitive impairment conditions in elderly are defined by progressive loss of neurons, based mostly on oxidative stress, long-term neuroinflammation, and compromised neuroplasticity. In the midst of increasing investigation for natural drugs, Moringa oleifera, a plant highly accepted for its high nutritional and phytochemical constitution, has become an active candidate with multi-oriented neuroprotective activity. This review discusses the therapeutic potential of Moringa oleifera in neurodegeneration, based on its antioxidant, anti-inflammatory, and neuroprotective activities. The plant's bioactive molecules, flavonoids, phenolic acids, and vitamins exhibit potent free radical-scavenging activity and the ability to modulate crucial inflammatory signaling pathways, like NF-κB and MAPK signaling. Additionally, Moringa oleifera is shown to possess the potential for enhancing neurogenesis, facilitating synaptic plasticity, and neuronal apoptosis protection. Preclinical evidence supports its efficacy in decreasing neuropathological alterations and enhancing cognitive function, whereas initial clinical data suggest a benign safety profile. In spite of these promising observations, additional work is required to confirm its action in human subjects and to standardize therapeutic regimens. This review highlights the promise of Moringa oleifera as an adjunct treatment for the prevention and management of neurodegenerative disorders and points to avenues for future investigation and clinical utility.Neurodegenerative disorders like Alzheimer's disease, Parkinson's disease, and other cognitive impairment conditions in elderly are defined by progressive loss of neurons, based mostly on oxidative stress, long-term neuroinflammation, and compromised neuroplasticity. In the midst of increasing investigation for natural drugs, Moringa oleifera, a plant highly accepted for its high nutritional and phytochemical constitution, has become an active candidate with multi-oriented neuroprotective activity. This review discusses the therapeutic potential of Moringa oleifera in neurodegeneration, based on its antioxidant, anti-inflammatory, and neuroprotective activities. The plant's bioactive molecules, flavonoids, phenolic acids, and vitamins exhibit potent free radical-scavenging activity and the ability to modulate crucial inflammatory signaling pathways, like NF-κB and MAPK signaling. Additionally, Moringa oleifera is shown to possess the potential for enhancing neurogenesis, facilitating synaptic plasticity, and neuronal apoptosis protection. Preclinical evidence supports its efficacy in decreasing neuropathological alterations and enhancing cognitive function, whereas initial clinical data suggest a benign safety profile. In spite of these promising observations, additional work is required to confirm its action in human subjects and to standardize therapeutic regimens. This review highlights the promise of Moringa oleifera as an adjunct treatment for the prevention and management of neurodegenerative disorders and points to avenues for future investigation and clinical utility. Neurodegenerative disorders like Alzheimer's disease, Parkinson's disease, and other cognitive impairment conditions in elderly are defined by progressive loss of neurons, based mostly on oxidative stress, long-term neuroinflammation, and compromised neuroplasticity. In the midst of increasing investigation for natural drugs, Moringa oleifera, a plant highly accepted for its high nutritional and phytochemical constitution, has become an active candidate with multi-oriented neuroprotective activity. This review discusses the therapeutic potential of Moringa oleifera in neurodegeneration, based on its antioxidant, anti-inflammatory, and neuroprotective activities. The plant's bioactive molecules, flavonoids, phenolic acids, and vitamins exhibit potent free radical-scavenging activity and the ability to modulate crucial inflammatory signaling pathways, like NF-κB and MAPK signaling. Additionally, Moringa oleifera is shown to possess the potential for enhancing neurogenesis, facilitating synaptic plasticity, and neuronal apoptosis protection. Preclinical evidence supports its efficacy in decreasing neuropathological alterations and enhancing cognitive function, whereas initial clinical data suggest a benign safety profile. In spite of these promising observations, additional work is required to confirm its action in human subjects and to standardize therapeutic regimens. This review highlights the promise of Moringa oleifera as an adjunct treatment for the prevention and management of neurodegenerative disorders and points to avenues for future investigation and clinical utility. |
Author | Goel, Falguni |
Author_xml | – sequence: 1 givenname: Falguni orcidid: 0009-0005-1599-812X surname: Goel fullname: Goel, Falguni |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40448817$$D View this record in MEDLINE/PubMed |
BookMark | eNo9kc9u3CAQxlGVKtmkeYEeKo49xOlgMODcqij_pES9tGeE8TihsmEDdpR9grx22N20SOjTzPcDjeY7JgchBiTkK4NzBqB-ZAZKqwrqpgKmWlFtPpEVa6SuGgn6gKygLZaQbX1EjnP-CwBSyfaQHAkQQmumVuTt6nU9xuTDI52fcHuTXeMye0dTHJHGgT7sbEtL6YdiUx9owCXFHh8xlMbsY7igNhR99X3Rs11R-TCMdprsHNNm2-r3z9Ypzuhm_4J0Qvdkg89T_kI-D3bMePqhJ-TP9dXvy9vq_tfN3eXP-8rVjZwr4VDXjDtoZcc5dICoe-RaWdk5jRxsh6KcshNhnRpQWN0V0knbDapz_IR83_9bpnheMM9m8tnhONqAccmG10zwWjbQFPTbB7p0E_Zmnfxk08b8W14B6j3gUsw54fAfYWC2CZl9QqZMY3YJmQ1_BxIJh8g |
Cites_doi | 10.3390/metabo12070608 10.1093/braincomms/fcad356 10.1039/D4FO03549F 10.1007/s11011-020-00556-9 10.1002/biof.1716 10.1080/10408398.2018.1546668 10.1007/s00702-024-02813-y 10.5530/pj.2018.6s.20 10.1007/s11101-023-09894-9 10.3390/pharmaceutics14102210 10.1155/2024/7694516 10.3390/jcm14051703 10.3390/nu15153454 10.3390/ijms17091454 10.1080/1028415X.2018.1500124 10.1007/978-981-15-4909-0_9 10.3389/fnut.2024.1448130 10.1002/ptr.8079 10.1038/s41392-025-02145-7 10.2174/0118715273325667241212041540 10.3390/molecules30040922 10.3390/biomedicines12061169 10.3389/fimmu.2023.1305933 10.1080/13880209.2016.1223146 10.3923/rjp.2023.01.12 10.1038/s41598-025-97232-8 10.3390/antiox14010074 10.1016/j.heliyon.2024.e27807 10.1038/s41580-024-00757-5 10.4103/pr.pr_101_17 10.1201/9781003392941 10.1016/j.jafr.2024.101217 10.1038/s41380-023-02360-0 10.1016/j.jep.2014.06.037 10.1016/j.jep.2024.117904 10.3390/foods13081153 10.2174/0118715303269893231207071440 10.3390/laws13010010 10.1016/j.phytochem.2014.03.028 10.2174/0109298673344501250109210447 10.32604/biocell.2024.058405 10.1002/ptr.5325 10.1007/s00210-025-03976-5 10.1021/acs.jafc.5c00252 10.1080/07391102.2024.2335300 10.1016/j.arres.2024.100113 10.3389/fphar.2022.1035220 10.1002/mnfr.202400525 10.3390/ijms25063264 10.1038/s41598-023-50600-8 10.3389/fphar.2012.00024 10.1108/NFS-03-2020-0087 10.1002/adhm.202304180 10.1007/s11033-021-06535-2 10.1093/nutrit/nuae025 10.1002/fsn3.4706 10.3390/ddc4010004 10.3390/brainsci13091258 10.1007/978-3-031-28780-0_9 10.24853/mujg.5.1.1-13 10.1007/978-3-030-69677-1_9-1 10.1016/j.phyplu.2024.100532 10.12688/f1000research.157194.2 10.3390/foods13070978 10.1016/j.phrs.2024.107300 10.3390/ijms26072916 10.3390/ijms24032098 10.1186/s40643-025-00861-0 10.1002/fsn3.4312 10.1016/j.jep.2023.117153 10.3390/cells14070511 10.1016/j.ejmech.2024.116359 |
ContentType | Journal Article |
Copyright | 2025. The Author(s), under exclusive licence to Springer Nature Switzerland AG. |
Copyright_xml | – notice: 2025. The Author(s), under exclusive licence to Springer Nature Switzerland AG. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1007/s10787-025-01794-y |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1568-5608 |
EndPage | 3669 |
ExternalDocumentID | 40448817 10_1007_s10787_025_01794_y |
Genre | Journal Article Review |
GroupedDBID | --- -Y2 -~C .86 .VR 06C 06D 0R~ 0VY 1N0 1SB 2.D 203 28- 29I 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2VQ 2~H 30V 36B 4.4 406 408 40D 40E 53G 5GY 5VS 67Z 6NX 8TC 8UJ 95- 95. 95~ 96X AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AAPKM AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYXX AAYZH ABAKF ABBBX ABBRH ABDBE ABDBF ABDZT ABECU ABFSG ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABRTQ ABSXP ABTEG ABTHY ABTKH ABTMW ABULA ABWNU ABXPI ACAOD ACDTI ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACSNA ACSTC ACUHS ACZOJ ADHHG ADHIR ADHKG ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYPR ADZKW AEBTG AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEVUW AEXYK AEZWR AFBBN AFDZB AFEXP AFHIU AFLOW AFOHR AFQWF AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGQPQ AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHPBZ AHSBF AHWEU AHYZX AIAKS AIGIU AIIXL AILAN AITGF AIXLP AJBLW AJRNO AJZVZ AKMHD ALMA_UNASSIGNED_HOLDINGS ALWAN AMFWP AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG ATHPR AVWKF AXYYD AYFIA AZFZN B-. B0M BA0 BBWZM BDATZ BGNMA BSONS CAG CITATION COF CS3 CSCUP DDRTE DNIVK DPUIP DU5 EAP EAS EBLON EBS EIOEI EJD EMB EMK EMOBN EN4 ESBYG EST ESX F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ7 H13 HF~ HG5 HG6 HMJXF HRMNR HVGLF HZ~ IHE IJ- IKXTQ IMOTQ ITM IWAJR IXC IZQ I~X I~Z J-C J0Z JBSCW JZLTJ KAT KDC KOV KPH LLZTM M4Y MA- MK0 N2Q NB0 NDZJH NF0 NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OVD P19 P9S PF0 PT4 PT5 QOK QOR QOS R4E R89 R9I RHV RNI ROL RPX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SBL SBY SCLPG SDH SDM SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZN T13 T16 TEORI TSG TSK TSV TT1 TUC TUS U2A U9L UG4 UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WK8 YLTOR Z45 ZMTXR ZOVNA ~8M ~A9 ~EX CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c256t-4ce8213c096b330b0ee8de387a6bc8e30abe44440254ac7fe4a8bb33c6abf7bc3 |
ISSN | 0925-4692 1568-5608 |
IngestDate | Fri Jul 11 17:11:04 EDT 2025 Wed Sep 03 02:12:55 EDT 2025 Thu Aug 21 00:38:46 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Keywords | Oxidative stress Neuroinflammation Anti-oxidant Anti-inflammatory Moringa Oleifera |
Language | English |
License | 2025. The Author(s), under exclusive licence to Springer Nature Switzerland AG. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c256t-4ce8213c096b330b0ee8de387a6bc8e30abe44440254ac7fe4a8bb33c6abf7bc3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
ORCID | 0009-0005-1599-812X |
PMID | 40448817 |
PQID | 3214326505 |
PQPubID | 23479 |
PageCount | 17 |
ParticipantIDs | proquest_miscellaneous_3214326505 pubmed_primary_40448817 crossref_primary_10_1007_s10787_025_01794_y |
PublicationCentury | 2000 |
PublicationDate | 2025-07-01 |
PublicationDateYYYYMMDD | 2025-07-01 |
PublicationDate_xml | – month: 07 year: 2025 text: 2025-07-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland |
PublicationTitle | Inflammopharmacology |
PublicationTitleAlternate | Inflammopharmacology |
PublicationYear | 2025 |
References | MA Elizabeth (1794_CR30) 2020; 35 MJ Rao (1794_CR70) 2025; 14 AM Thawabteh (1794_CR88) 2025; 30 N Guo (1794_CR38) 2024; 9 A Trela-Makowej (1794_CR89) 2022; 12 A Houldsworth (1794_CR41) 2024; 6 J Ceramella (1794_CR20) 2024; 13 A Smith (1794_CR81) 2014; 158 L Fornari Laurindo (1794_CR32) 2024; 14 AA Al-Gendy (1794_CR5) 2016; 54 I Grabska-Kobyłecka (1794_CR37) 2023; 15 P Mostashari (1794_CR57) 2024; 13 J Allen (1794_CR7) 2024; 29 JK Paul (1794_CR66) 2024; 31 UK Azlan (1794_CR11) 2023; 13 E Camilleri (1794_CR19) 2024 S Jamil (1794_CR42) 2025; 13 R Baishya (1794_CR12) 2020; 2020 1794_CR75 G Sita (1794_CR80) 2016; 17 D Zhao (1794_CR94) 2020; 60 G Srivastava (1794_CR84) 2024; 4 S Habtemariam (1794_CR39) 2024; 12 I Ara (1794_CR9) 2022; 23 GM El-Sherbiny (1794_CR31) 2024; 14 A Mohajan (1794_CR55) 2023 1794_CR72 1794_CR78 F Gao (1794_CR34) 2025; 15 M Battaglini (1794_CR15) 2024; 13 N Kumar (1794_CR49) 2023; 13 M Akbari (1794_CR3) 2025; 12 IA Bhat (1794_CR16) 2025 AR Khalatbary (1794_CR48) 2020; 23 R Basu (1794_CR14) 2023; 31 P Joshi (1794_CR46) 2025; 56 CV Mashamaite (1794_CR51) 2024; 20 JA Soto (1794_CR83) 2025; 13 MN Javed (1794_CR43) 2020; 2020 H Mahaveerchand (1794_CR50) 2024; 18 M Naoi (1794_CR59) 2025; 26 S Sabat (1794_CR74) 2025; 12 M Mbikay (1794_CR53) 2012; 3 S Adarthaiya (1794_CR2) 2024; 38 M Masoumvand (1794_CR52) 2024; 24 A Memarzia (1794_CR54) 2021; 47 S Hasan (1794_CR40) 2023; 13 N Chaachouay (1794_CR21) 2025; 4 AA Aljabali (1794_CR6) 2025 EY Villegas-Vazquez (1794_CR91) 2025; 13 NI Soliman (1794_CR82) 2021; 64 JI Obeme-Nmom (1794_CR64) 2024 E Sulastri (1794_CR86) 2018 YR Dewi (1794_CR27) 2024; 5 S Jin (1794_CR45) 2023; 165 J Akhtar (1794_CR4) 2024 A Pareek (1794_CR65) 2023; 24 MA Elawad (1794_CR29) 2024; 68 R Rathi (1794_CR71) 2022; 14 DL Dantas (1794_CR24) 2024; 325 M Shahbaz (1794_CR77) 2024; 12 SJ Stohs (1794_CR85) 2015; 29 BO Popescu (1794_CR67) 2024; 131 B Alsuwayt (1794_CR8) 2025; 6 CT Nemade (1794_CR61) 2025; 13 R Bhushan (1794_CR17) 2025 A Azargoonjahromi (1794_CR10) 2025; 83 B Worku (1794_CR93) 2024; 2024 T Premkumar (1794_CR68) 2024; 10 C Niu (1794_CR62) 2024; 11 C Waterman (1794_CR92) 2014; 103 Q Jiang (1794_CR44) 2025; 10 NJ Dar (1794_CR25) 2020; 256 F Goel (1794_CR36) 2025 MP Bimantio (1794_CR18) 2025; 2025 M Ramakrishnan (1794_CR69) 2024; 11 NR Selvaraj (1794_CR76) 2025; 14 E Gkintoni (1794_CR35) 2025; 14 MR Singh (1794_CR79) 2023 M Gachowska (1794_CR33) 2021; 48 V Suryadevara (1794_CR87) 2018 SC da Renata (1794_CR23) 2025 S Darekar (1794_CR26) 2024 A Bangar (1794_CR13) 2024; 319 1794_CR60 P Upadhyay (1794_CR90) 2024; 23 D Kathuria (1794_CR47) 2023 N Chhikara (1794_CR22) 2021; 51 NH Do (1794_CR28) 2022; 294 RA Nixon (1794_CR63) 2024; 25 YM Abd-Elhakim (1794_CR1) 2025 J Morán (1794_CR56) 2024; 13 A Muscolo (1794_CR58) 2024; 25 |
References_xml | – volume: 12 start-page: 608 issue: 7 year: 2022 ident: 1794_CR89 publication-title: Metabolites doi: 10.3390/metabo12070608 – volume: 6 start-page: fcad356 issue: 1 year: 2024 ident: 1794_CR41 publication-title: Brain Commun. doi: 10.1093/braincomms/fcad356 – start-page: 49 volume-title: Fruits as a Functional Food for Health. Functional Foods year: 2023 ident: 1794_CR47 – year: 2024 ident: 1794_CR64 publication-title: Food Function doi: 10.1039/D4FO03549F – volume: 35 start-page: 829 year: 2020 ident: 1794_CR30 publication-title: Metab Brain Dis doi: 10.1007/s11011-020-00556-9 – volume: 47 start-page: 311 issue: 3 year: 2021 ident: 1794_CR54 publication-title: BioFactors doi: 10.1002/biof.1716 – volume: 60 start-page: 597 issue: 4 year: 2020 ident: 1794_CR94 publication-title: Critical Rev Food Sci Nutr doi: 10.1080/10408398.2018.1546668 – volume: 131 start-page: 1329 issue: 11 year: 2024 ident: 1794_CR67 publication-title: J Neural Transmiss doi: 10.1007/s00702-024-02813-y – year: 2018 ident: 1794_CR86 publication-title: Pharmacognosy J doi: 10.5530/pj.2018.6s.20 – volume: 23 start-page: 485 issue: 2 year: 2024 ident: 1794_CR90 publication-title: Phytochemistry Rev doi: 10.1007/s11101-023-09894-9 – volume: 14 start-page: 2210 issue: 10 year: 2022 ident: 1794_CR71 publication-title: Pharmaceutics doi: 10.3390/pharmaceutics14102210 – ident: 1794_CR75 – volume: 2024 start-page: 7694516 issue: 1 year: 2024 ident: 1794_CR93 publication-title: Oxidative Med Cellular Longev doi: 10.1155/2024/7694516 – volume: 14 start-page: 1703 issue: 5 year: 2025 ident: 1794_CR35 publication-title: J Clin Med doi: 10.3390/jcm14051703 – volume: 15 start-page: 3454 issue: 15 year: 2023 ident: 1794_CR37 publication-title: Nutrients doi: 10.3390/nu15153454 – volume: 17 start-page: 1454 issue: 9 year: 2016 ident: 1794_CR80 publication-title: Int J Mol Sci doi: 10.3390/ijms17091454 – volume: 23 start-page: 281 issue: 4 year: 2020 ident: 1794_CR48 publication-title: Nutr Neurosci doi: 10.1080/1028415X.2018.1500124 – volume: 2020 start-page: 151 year: 2020 ident: 1794_CR43 publication-title: Nanophytomed Concept Clin doi: 10.1007/978-981-15-4909-0_9 – volume: 11 start-page: 1448130 year: 2024 ident: 1794_CR69 publication-title: Front Nutr doi: 10.3389/fnut.2024.1448130 – volume: 38 start-page: 755 issue: 2 year: 2024 ident: 1794_CR2 publication-title: Phytotherapy Res doi: 10.1002/ptr.8079 – volume: 10 start-page: 76 issue: 1 year: 2025 ident: 1794_CR44 publication-title: Signal Transduct Target Ther doi: 10.1038/s41392-025-02145-7 – year: 2025 ident: 1794_CR17 publication-title: CNS Neurol Disord-Drug Targets doi: 10.2174/0118715273325667241212041540 – volume-title: Phytopharmaceuticals and Herbal Drugs: Prospects and Safety Issues in the Delivery of Natural Products year: 2023 ident: 1794_CR79 – volume-title: Moringa oleifera: A comprehensive review on pharmacology, phytochemistry, and clinical applications year: 2024 ident: 1794_CR26 – volume: 30 start-page: 922 issue: 4 year: 2025 ident: 1794_CR88 publication-title: Molecules doi: 10.3390/molecules30040922 – volume: 294 year: 2022 ident: 1794_CR28 publication-title: Carbohydrate Polymers – volume: 2020 start-page: 175 year: 2020 ident: 1794_CR12 publication-title: Herbal Med India Indigenous Knowl Pract Innov Value – volume: 12 start-page: 1169 issue: 6 year: 2024 ident: 1794_CR39 publication-title: Biomedicines doi: 10.3390/biomedicines12061169 – volume: 14 start-page: 1305933 year: 2024 ident: 1794_CR32 publication-title: Front Immunol doi: 10.3389/fimmu.2023.1305933 – volume: 54 start-page: 3257 issue: 12 year: 2016 ident: 1794_CR5 publication-title: Pharmaceutical Biol doi: 10.1080/13880209.2016.1223146 – volume: 18 start-page: 1 year: 2024 ident: 1794_CR50 publication-title: Phytochem Rev. doi: 10.3923/rjp.2023.01.12 – volume: 13 start-page: 297 year: 2025 ident: 1794_CR61 publication-title: Pharmacog Phytochem Principles Techniq Clin App. – volume: 15 start-page: 11807 issue: 1 year: 2025 ident: 1794_CR34 publication-title: Sci Rep doi: 10.1038/s41598-025-97232-8 – volume: 14 start-page: 74 issue: 1 year: 2025 ident: 1794_CR70 publication-title: Antioxidants doi: 10.3390/antiox14010074 – year: 2024 ident: 1794_CR19 publication-title: Heliyon doi: 10.1016/j.heliyon.2024.e27807 – volume: 25 start-page: 926 issue: 11 year: 2024 ident: 1794_CR63 publication-title: Nat Rev Mol Cell Biol doi: 10.1038/s41580-024-00757-5 – year: 2018 ident: 1794_CR87 publication-title: Pharmacognosy Res doi: 10.4103/pr.pr_101_17 – volume: 13 start-page: 634 issue: 3 year: 2025 ident: 1794_CR91 publication-title: Biomed – volume: 6 start-page: 1 year: 2025 ident: 1794_CR8 publication-title: Inflammopharmacology. – volume-title: Medicinal Plants for the Management of Neurodegenerative Diseases year: 2024 ident: 1794_CR4 doi: 10.1201/9781003392941 – volume: 20 start-page: 101217 year: 2024 ident: 1794_CR51 publication-title: J Agricul Food Res. doi: 10.1016/j.jafr.2024.101217 – volume: 13 start-page: 13 issue: 8 year: 2023 ident: 1794_CR49 publication-title: Nat Products J – volume: 29 start-page: 671 issue: 3 year: 2024 ident: 1794_CR7 publication-title: Mol Psychiatry doi: 10.1038/s41380-023-02360-0 – volume: 158 start-page: 507 year: 2014 ident: 1794_CR81 publication-title: J Ethnopharmacol doi: 10.1016/j.jep.2014.06.037 – volume: 325 year: 2024 ident: 1794_CR24 publication-title: Journal of Ethnopharmacology doi: 10.1016/j.jep.2024.117904 – volume: 13 start-page: 1153 issue: 8 year: 2024 ident: 1794_CR57 publication-title: Foods doi: 10.3390/foods13081153 – volume: 24 start-page: 1355 issue: 12 year: 2024 ident: 1794_CR52 publication-title: EMIDDT doi: 10.2174/0118715303269893231207071440 – volume: 13 start-page: 10 issue: 1 year: 2024 ident: 1794_CR56 publication-title: Laws doi: 10.3390/laws13010010 – volume: 103 start-page: 114 year: 2014 ident: 1794_CR92 publication-title: Phytochemistry doi: 10.1016/j.phytochem.2014.03.028 – year: 2025 ident: 1794_CR6 publication-title: Curr Med Chem doi: 10.2174/0109298673344501250109210447 – year: 2025 ident: 1794_CR23 publication-title: Biocell doi: 10.32604/biocell.2024.058405 – volume: 23 start-page: 1 year: 2022 ident: 1794_CR9 publication-title: Int J Curr Res Physiol Pharmacol. – volume: 29 start-page: 796 issue: 6 year: 2015 ident: 1794_CR85 publication-title: Phytotherap Res doi: 10.1002/ptr.5325 – year: 2025 ident: 1794_CR36 publication-title: Naunyn-Schmiedeberg's Arch Pharmacol doi: 10.1007/s00210-025-03976-5 – year: 2025 ident: 1794_CR1 publication-title: J Agricul Food Chem doi: 10.1021/acs.jafc.5c00252 – volume: 2025 start-page: 5 year: 2025 ident: 1794_CR18 publication-title: Commun Math Biol Neurosci. – volume: 10 start-page: 1 year: 2024 ident: 1794_CR68 publication-title: J Biomol Struct Dyn. doi: 10.1080/07391102.2024.2335300 – volume: 31 start-page: 100113 year: 2024 ident: 1794_CR66 publication-title: Adv Redox Res doi: 10.1016/j.arres.2024.100113 – volume: 56 start-page: 152 issue: 1 year: 2025 ident: 1794_CR46 publication-title: Indian J Prevent Soc Med – volume: 13 start-page: 1035220 year: 2023 ident: 1794_CR11 publication-title: Front Pharmacol doi: 10.3389/fphar.2022.1035220 – volume-title: Quality evaluation of novel biscuits supplimented with watermelon (Citrullus lanatus) seeds and Moringa (Moringa oleifera) leaves powder year: 2023 ident: 1794_CR55 – volume: 68 start-page: 2400525 issue: 24 year: 2024 ident: 1794_CR29 publication-title: Mol Nutr Food Res doi: 10.1002/mnfr.202400525 – volume: 25 start-page: 3264 issue: 6 year: 2024 ident: 1794_CR58 publication-title: Int J Mol Sci doi: 10.3390/ijms25063264 – ident: 1794_CR60 – volume: 14 start-page: 1 issue: 1 year: 2024 ident: 1794_CR31 publication-title: Sci Rep doi: 10.1038/s41598-023-50600-8 – volume: 3 start-page: 24 year: 2012 ident: 1794_CR53 publication-title: Front Pharmacol doi: 10.3389/fphar.2012.00024 – volume: 51 start-page: 255 issue: 2 year: 2021 ident: 1794_CR22 publication-title: Nutr Food Sci doi: 10.1108/NFS-03-2020-0087 – volume: 13 start-page: 2304180 issue: 12 year: 2024 ident: 1794_CR15 publication-title: Adv Healthcare Mater doi: 10.1002/adhm.202304180 – volume: 48 start-page: 5689 issue: 7 year: 2021 ident: 1794_CR33 publication-title: Mol Biol Rep doi: 10.1007/s11033-021-06535-2 – volume: 83 start-page: e257 issue: 2 year: 2025 ident: 1794_CR10 publication-title: Nutr Rev doi: 10.1093/nutrit/nuae025 – volume: 13 issue: 1 year: 2025 ident: 1794_CR42 publication-title: Food Sci Nutr doi: 10.1002/fsn3.4706 – volume: 4 start-page: 4 issue: 1 year: 2025 ident: 1794_CR21 publication-title: Drugs Drug Candidates doi: 10.3390/ddc4010004 – volume: 13 start-page: 1258 issue: 9 year: 2023 ident: 1794_CR40 publication-title: Brain Sci doi: 10.3390/brainsci13091258 – volume: 31 start-page: 253 year: 2023 ident: 1794_CR14 publication-title: Bioprospect Trop Med Plant doi: 10.1007/978-3-031-28780-0_9 – volume: 256 year: 2020 ident: 1794_CR25 publication-title: Journal of ethnopharmacology – volume: 5 start-page: 1 issue: 1 year: 2024 ident: 1794_CR27 publication-title: Muhammadiyah J Geriatr doi: 10.24853/mujg.5.1.1-13 – ident: 1794_CR72 – ident: 1794_CR78 doi: 10.1007/978-3-030-69677-1_9-1 – volume: 4 issue: 2 year: 2024 ident: 1794_CR84 publication-title: Phytomedicine Plus doi: 10.1016/j.phyplu.2024.100532 – volume: 13 start-page: 1390 year: 2025 ident: 1794_CR83 publication-title: F1000Research doi: 10.12688/f1000research.157194.2 – volume: 13 start-page: 978 issue: 7 year: 2024 ident: 1794_CR20 publication-title: Foods doi: 10.3390/foods13070978 – volume: 9 start-page: 107300 year: 2024 ident: 1794_CR38 publication-title: Pharmacol Res. doi: 10.1016/j.phrs.2024.107300 – volume: 26 start-page: 2916 issue: 7 year: 2025 ident: 1794_CR59 publication-title: Int J Mol Sci doi: 10.3390/ijms26072916 – volume: 64 start-page: 5585 issue: 10 year: 2021 ident: 1794_CR82 publication-title: Egypt J Chem – volume: 12 start-page: 867 issue: 4 year: 2025 ident: 1794_CR3 publication-title: Int J New Chem – volume: 24 start-page: 2098 issue: 3 year: 2023 ident: 1794_CR65 publication-title: Int J Mol Sci doi: 10.3390/ijms24032098 – volume: 165 year: 2023 ident: 1794_CR45 publication-title: Biomed Pharmacother – volume-title: Apoptosis-mechanisms, regulation in pathology, and therapeutic potential year: 2025 ident: 1794_CR16 – volume: 12 start-page: 27 issue: 1 year: 2025 ident: 1794_CR74 publication-title: Bioresourc Bioprocess doi: 10.1186/s40643-025-00861-0 – volume: 12 start-page: 6157 issue: 9 year: 2024 ident: 1794_CR77 publication-title: Food Sci Nutrition doi: 10.1002/fsn3.4312 – volume: 319 year: 2024 ident: 1794_CR13 publication-title: J Ethnopharmacol doi: 10.1016/j.jep.2023.117153 – volume: 14 start-page: 511 issue: 7 year: 2025 ident: 1794_CR76 publication-title: Cells doi: 10.3390/cells14070511 – volume: 11 start-page: 116359 year: 2024 ident: 1794_CR62 publication-title: European J Med Chem doi: 10.1016/j.ejmech.2024.116359 |
SSID | ssj0006769 |
Score | 2.373185 |
SecondaryResourceType | review_article |
Snippet | Neurodegenerative disorders like Alzheimer's disease, Parkinson's disease, and other cognitive impairment conditions in elderly are defined by progressive loss... |
SourceID | proquest pubmed crossref |
SourceType | Aggregation Database Index Database |
StartPage | 3653 |
SubjectTerms | Animals Anti-Inflammatory Agents - isolation & purification Anti-Inflammatory Agents - pharmacology Antioxidants - isolation & purification Antioxidants - pharmacology Humans Moringa oleifera - chemistry Neurodegenerative Diseases - drug therapy Neurodegenerative Diseases - metabolism Neuroprotective Agents - isolation & purification Neuroprotective Agents - pharmacology Oxidative Stress - drug effects Plant Extracts - isolation & purification Plant Extracts - pharmacology |
Title | Exploring the therapeutic role of Moringa oleifera in neurodegeneration: antioxidant, anti-inflammatory, and neuroprotective mechanisms |
URI | https://www.ncbi.nlm.nih.gov/pubmed/40448817 https://www.proquest.com/docview/3214326505 |
Volume | 33 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZZB2MvZetu2Q0NRl8aDdmyZbVvZayUQUcfEuibkezjkrHapUnYsj-wv72jiy9LVliXBxErsazwfTnSkb5zRMj7VBiIpOEsUTrFAgxTQh8yCVml0SXi0jiV7xd5Oks-X6QXo9H3YXTJ0nwofv41ruR_UMU6xNVGyd4B2a5RrMD3iC-WiDCW_4RxL6Cz08dBKFUnGjxzH-sDvLQaFm2XN1wKyxIuXcLpVtuhrerxx7zUPg-BvWTYReTLlduHb1We7uaQ3MGKjq7Ahg7PFyHp-ddWGO_ubK77xNi9arTxwoAT_e1yVc-Hyw5x2klUu_VDrEPf2ptSCNbThnFJrobm1ee5CDTKBrZSSJ8mOIy7QvozW7ZsOm9jnNG2MNcTa0TYuh_B2l37jYGtkxv2qZltGzm2kbs28vU9cj9G_8IefTGLj7sh3Op-XZLG8BtDtFWIudzox58zmlvcFDddmT4iu8HPoMeeNI_JCOo98uAsKCn2yP65h2Y9odOeN4sJ3afnA9CekF8dySgSjA5IRi3JaFPRQDLakozOa7pFsiM6oNiEbhHMVpV0g160p9dTMjv5NP14ysLpHazAafSSJQWoOBIF-shGCG44gCpBqExLUygQXBtI8GXTMegiqyDRyuA3C6lNlZlCPCM7dVPDC0JFhNNOBVGW8TKBlBtQVVRUqY6hlMqIMTloEcivfZKW_HbMx-RdC1KOttRukOkamtUit4d2oTuDTsGYPPfode0lPMGxLspe3ulZr8jD_s_zmuwsb1bwBmexS_PWMe43hkigZw |
linkProvider | Springer Nature |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Exploring+the+therapeutic+role+of+Moringa+oleifera+in+neurodegeneration%3A+antioxidant%2C+anti-inflammatory%2C+and+neuroprotective+mechanisms&rft.jtitle=Inflammopharmacology&rft.au=Goel%2C+Falguni&rft.date=2025-07-01&rft.issn=0925-4692&rft.eissn=1568-5608&rft.volume=33&rft.issue=7&rft.spage=3653&rft.epage=3669&rft_id=info:doi/10.1007%2Fs10787-025-01794-y&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s10787_025_01794_y |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0925-4692&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0925-4692&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0925-4692&client=summon |